Kent Lake PR’s CareDx CDNA Stock Holding History

Kent Lake PR’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$8M	Buy	+550,000	New	+$7.84M	4.04%	9

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Kent Lake PR's CDNA Position: Q3 2025 in Review

Kent Lake PR opened a new position in CareDx (CDNA) in Q3 2025: 550,000 shares worth $8M. The stake represents 4.04% of the portfolio and ranks #9 among its holdings.

187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

Kent Lake PR held 550,000 shares of CareDx worth $8M as of Q3 2025.
CareDx was a new Kent Lake PR position in Q3 2025.
CareDx made up 4.04% of Kent Lake PR's portfolio in Q3 2025, its #9 holding.
187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Kent Lake PR's 13F filing for Q3 2025, filed 14 Nov 2025.